Yasuhiro Hida
Overview
Explore the profile of Yasuhiro Hida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
2695
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shiraishi Y, Omasa M, Yamashita S, Hyung-Eun Y, Tanahashi M, Fukami T, et al.
Gen Thorac Cardiovasc Surg
. 2025 Feb;
PMID: 39969668
This article translates the guidelines for the treatment of empyema established by the Japanese Association of Chest Surgery in 2023 from Japanese to English. These guidelines were developed by the...
2.
Jia Z, Maishi N, Takekawa H, Matsuda A, Nakade T, Nakamura T, et al.
Cancer Med
. 2024 Dec;
13(23):e70462.
PMID: 39629553
Background: Inflammation is one of the hallmarks of cancer and is associated with tumor growth. Tumor endothelial cells (TECs) demonstrate inflamed phenotypes. Endothelial inflammation initiates thrombus formation, which is the...
3.
Shingu Y, Yokota I, Kato T, Hida Y, Kaga K, Gao J, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458176
L-carnitine is essential in lipid metabolism and reportedly has preventive effects for arrhythmia. Our objective was to examine the incidence of postoperative atrial fibrillation (POAF) and changes in serum biomarker...
4.
Suzuki T, Kano S, Suzuki M, Hamada S, Idogawa H, Tsushima N, et al.
Int J Clin Oncol
. 2024 Apr;
29(6):735-743.
PMID: 38649649
Background: Photoimmunotherapy is a treatment modality that induces targeted cell death by binding a molecular-targeted drug activated by infrared light to the tumor cells and subsequently illuminating the lesion with...
5.
Fujiwara-Kuroda A, Aragaki M, Hida Y, Ujiie H, Ohtaka K, Shiiya H, et al.
Transl Lung Cancer Res
. 2024 Apr;
13(3):603-611.
PMID: 38601444
When performing thoracoscopic partial resections of nonpalpable lung tumors such as ground-glass opacities (GGOs) and small tumors, detecting the location of the lesion and assessing the resection margins can be...
6.
Tsumita T, Takeda R, Maishi N, Hida Y, Sasaki M, Orba Y, et al.
Aging Cell
. 2023 Dec;
23(2):e14050.
PMID: 38098255
Thrombosis is the major cause of death in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and the pathology of vascular endothelial cells (ECs) has received much attention. Although there...
7.
Yu L, Hong Y, Maishi N, Matsuda A, Hida Y, Hasebe A, et al.
Cancer Sci
. 2023 Dec;
115(2):648-659.
PMID: 38096871
Thrombosis is a well-known cardiovascular disease (CVD) complication that has caused death in many patients with cancer. Oral bacteria have been reported to contribute to systemic diseases, including CVDs, and...
8.
Hasegawa S, Shintani Y, Takuwa T, Aoe K, Kato K, Fujimoto N, et al.
Cancer Sci
. 2023 Dec;
115(2):507-528.
PMID: 38047872
Due to the scarcity of large-sized prospective databases, the Japanese Joint Committee for Lung Cancer Registry conducted a nationwide prospective registry for newly diagnosed and untreated pleural mesothelioma. All new...
9.
Kikuchi H, Maishi N, Yu L, Jia Z, Li C, Sato M, et al.
Br J Cancer
. 2023 Nov;
130(2):336-345.
PMID: 38036665
Background: Conventional chemotherapy is based on the maximum tolerated dose (MTD) and requires treatment-free intervals to restore normal host cells. MTD chemotherapy may induce angiogenesis or immunosuppressive cell infiltration during...
10.
Yin Y, Sakakibara R, Honda T, Kirimura S, Daroonpan P, Kobayashi M, et al.
Thorac Cancer
. 2023 May;
14(20):1991-2000.
PMID: 37253418
Background: The efficacy of immune checkpoint inhibitors (ICIs) in pleural mesothelioma has recently been established. The response to ICIs can be predicted by quantitative analysis of cells and their spatial...